JPS5519257A - Medicine retard form - Google Patents
Medicine retard formInfo
- Publication number
- JPS5519257A JPS5519257A JP8917779A JP8917779A JPS5519257A JP S5519257 A JPS5519257 A JP S5519257A JP 8917779 A JP8917779 A JP 8917779A JP 8917779 A JP8917779 A JP 8917779A JP S5519257 A JPS5519257 A JP S5519257A
- Authority
- JP
- Japan
- Prior art keywords
- medicine
- retard form
- retard
- medicine retard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782831164 DE2831164A1 (de) | 1978-07-15 | 1978-07-15 | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5519257A true JPS5519257A (en) | 1980-02-09 |
Family
ID=6044470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8917779A Pending JPS5519257A (en) | 1978-07-15 | 1979-07-13 | Medicine retard form |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5519257A (ja) |
| DE (1) | DE2831164A1 (ja) |
| ES (1) | ES8100880A1 (ja) |
| HU (1) | HU179935B (ja) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6082131A (ja) * | 1983-10-12 | 1985-05-10 | Nagoya Yukagaku Kogyo Kk | フェノール樹脂用微小カプセル型硬化剤 |
| JPS62242615A (ja) * | 1986-04-16 | 1987-10-23 | Fujisawa Pharmaceut Co Ltd | マトリツクス錠 |
| JP2006508891A (ja) * | 2001-01-30 | 2006-03-16 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | 治療上有効な成分の長期放出/持続放出のための医薬組成物 |
| JP2008534681A (ja) * | 2006-02-09 | 2008-08-28 | テバ ファーマシューティカル インダストリーズ リミティド | ジピリダモール持続放出製剤及びそれを調製のための方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG860Y1 (bg) * | 2004-09-17 | 2007-02-28 | "Софарма" Ад | Лекарствена форма на дипиридамол |
-
1978
- 1978-07-15 DE DE19782831164 patent/DE2831164A1/de not_active Withdrawn
-
1979
- 1979-07-13 JP JP8917779A patent/JPS5519257A/ja active Pending
- 1979-07-13 HU HUBO001797 patent/HU179935B/hu unknown
- 1979-07-14 ES ES482496A patent/ES8100880A1/es not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6082131A (ja) * | 1983-10-12 | 1985-05-10 | Nagoya Yukagaku Kogyo Kk | フェノール樹脂用微小カプセル型硬化剤 |
| JPS62242615A (ja) * | 1986-04-16 | 1987-10-23 | Fujisawa Pharmaceut Co Ltd | マトリツクス錠 |
| JP2006508891A (ja) * | 2001-01-30 | 2006-03-16 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | 治療上有効な成分の長期放出/持続放出のための医薬組成物 |
| JP2008534681A (ja) * | 2006-02-09 | 2008-08-28 | テバ ファーマシューティカル インダストリーズ リミティド | ジピリダモール持続放出製剤及びそれを調製のための方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2831164A1 (de) | 1980-01-24 |
| ES482496A0 (es) | 1980-12-01 |
| ES8100880A1 (es) | 1980-12-01 |
| HU179935B (en) | 1983-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2085732B (en) | Administration set | |
| ZA794240B (en) | Novel dosage form | |
| GB2012759B (en) | Thienohydantoin derivatives | |
| JPS5514087A (en) | Capsule | |
| GB2020655B (en) | Pharmaceutical compounds | |
| GB2022079A (en) | L-leucyl-4-hydroxyanilide derivatives | |
| JPS54157842A (en) | Antiicorrosion preparation | |
| JPS54157817A (en) | Pharmaceutical prepared solution | |
| JPS5542684A (en) | Drug box | |
| GB2018757B (en) | 3-phenyltetrahydropyridine derivatives | |
| GB2017708B (en) | Steroid-spirooxazolidinone derivatives | |
| JPS5589231A (en) | Vaccine | |
| JPS5519257A (en) | Medicine retard form | |
| GB2021680B (en) | Latch-and-keeper mechanisms | |
| GB2017085B (en) | Preparation of -diamines | |
| GB2017691B (en) | 2-hydroxymethyl-pyrazine derivatives | |
| GB2019843B (en) | N-alkenylmoranoline derivatives | |
| JPS54151115A (en) | Poultice | |
| GB2024806B (en) | Onomycin derivatives | |
| GB2052477B (en) | Carbamoyl-piperazine derivatives | |
| JPS5527168A (en) | Drug composition | |
| GB2013187B (en) | Phenylpyrol derivatives | |
| GB2028660B (en) | Administration set | |
| JPS5587718A (en) | Medicine composition | |
| JPS5555114A (en) | Fine drug |